معرفی
Professor Liwei Zhang, M.D., serves as Director of Neurosurgery Department and Vice President of Beijing Tiantan Hospital, with Doctoral Supervisor appointments at Beijing Capital Medical University and Tsinghua University. He is Associate Director of China National Clinical Research Center for Neurological Diseases, Chairman of the Chinese Congress of Neurological Surgeons, and Committee member of the World Federation of Neurosurgical Societies.
His research pioneers skull-base and brainstem tumor treatment, focusing on brainstem glioma genetics and brain function protection. He established the National Brain Tumor Registry of China (NBTRC)—now the world's second-largest brain tumor database with 110,000+ clinical records—and developed non-invasive CSF ctDNA diagnostics for molecular profiling. His work includes identifying PPM1D mutations in brainstem glioma and creating patient-derived DIPG cell models.
Major recognitions include:
- 2018 National Science and Technology Progress Award of China (Second Prize)
- 2017 Beijing Science and Technology Progress Award (Second Prize)
- 2017 Chinese Medical Science Prize (Third Prize)
- 2017 Chinese Medical Science and Technology Progress Award (Third Prize)
- 2015 Beijing Medical Science and Technology Progress Award (Third Prize)
- 2015 Chinese Medical Science Prize (Third Prize)
- 2014 Chinese Medical Science Prize (Third Prize)
- 2006 Beijing Science and Technology Progress Award (Third Prize)
- 2006 Chinese Medical Science Prize (Second Prize)
He has mentored 30+ graduate students, secured 40+ million RMB in research funding, and established China's Multidisciplinary Cooperation System for Skull-based Tumors. As Chief of Beijing Key Laboratory of Brain Tumor Research, he leads NBTRC's global data-sharing initiatives for brain health studies.
